Mount Baker Nurse Practitioners Association

XARELTO® 2.5 MG Vascular Dose*: Reduction in the Risk of Major Cardiovascular Events† in Patients With Chronic CAD or PAD (ABV)

Posted by Michele Tulk in Pharmaceutical Rep Info

XARELTO® 2.5 MG Vascular Dose*: Reduction in the Risk of Major Cardiovascular Events† in Patients With Chronic CAD or PAD (ABV)

Posted in Pharmaceutical Rep Info